EMD Serono
Ongoing Platform and Resource Development
For over 20 years, EMD Serono has been utilizing their experience and research to develop groundbreaking Multiple Sclerosis (MS) treatments that improve patients' lives. To that end, they offer both Rebif and MAVENCLAD therapeutic options along with informative and educational resources that help people impacted by MS and their care partners.
Since 2015, WF has been the technology partner for the EMD Serono Neurology and Immunology team. WF has built and maintained targeted digital platforms for product information, patient materials and Health Care Professional (HCP) specific resources. These high-value applications need to be developed and deployed with a stringent level of data privacy, redundancy, and content agility.








